Form 8-K - Current report:
SEC Accession No. 0001683168-25-002790
Filing Date
2025-04-24
Accepted
2025-04-24 16:47:19
Documents
13
Period of Report
2025-04-24
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k.htm   iXBRL 8-K 33228
  Complete submission text file 0001683168-25-002790.txt   207129

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pmcb-20250424.xsd EX-101.SCH 3020
3 XBRL LABEL FILE pmcb-20250424_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE pmcb-20250424_pre.xml EX-101.PRE 22362
15 EXTRACTED XBRL INSTANCE DOCUMENT pharmacyte_8k_htm.xml XML 3679
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-40699 | Film No.: 25868299
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)